Multiple Roles for B-Lymphocytes in Sjogren's Syndrome

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Sjogren's syndrome (SS) is a chronic autoimmune disorder characterized by lymphocytic infiltration of exocrine glands, primarily salivary and lacrimal glands.
• The disease leads to significant morbidity, including dry eyes, dry mouth, and potential systemic complications like lymphoma.
• Pathogenesis involves a complex interplay of multiple immune cell types.

Approach:

• This review synthesizes current research on the immunological aspects of Sjogren's syndrome.
• It focuses specifically on the involvement of B lymphocytes in disease development and progression.
• The review examines the therapeutic strategies targeting B cells in SS management.

Key Points:

• Abnormal B cell subpopulations are frequently observed in patients with Sjogren's syndrome.
• B cells play critical roles in the autoimmune processes and tissue damage characteristic of SS.
• Emerging B cell-directed therapies show promise for managing SS symptoms and manifestations.

Conclusions:

• B cells are central players in the pathogenesis of Sjogren's syndrome.
• Targeting B cell pathways represents a viable therapeutic avenue for SS.
• Further research into B cell biology and targeted therapies is crucial for improving patient outcomes.